Sorrento's (SRNE) Scilex Appoints Laura Hamill to its Board Apr 13, 2022 05:40AM
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Strengthens Board of Directors with Appointment of Highly Accomplished Pharmaceutical and Biotechnology Executive, L Apr 12, 2022 09:15PM